DANWANG MEDICAL
Danwang Medical is a research organization focusing on regenerative medicine and organoid technology.
DANWANG MEDICAL
Industry:
Biopharma Biotechnology Medical Product Research
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.d1med.com
Status:
Active
Contact:
86-021-69106895
Email Addresses:
[email protected]
Total Funding:
18.63 M USD
Technology used in webpage:
Nginx HiChina DNS TrustAsia
Current Employees Featured
Founder
Investors List
Kunlun Capital
Kunlun Capital investment in Series A - Danwang Medical
Guofang Capital
Guofang Capital investment in Series A - Danwang Medical
Delian Capital
Delian Capital investment in Series A - Danwang Medical
Official Site Inspections
http://www.d1med.com
- Host name: 139.224.136.95
- IP address: 139.224.136.95
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Danwang Medical"
Danwang Medical - Crunchbase Company Profile & Funding
Danwang Medical is a research organization focusing on regenerative medicine and organoid technology.See details»
丹望医疗-类器官技术的领导者
丹望医疗科技（上海）有限公司，是国内领先的专注类器官技术的平台型公司。公司致力于将最新的再生医学临床转化技术，应用于疾病诊疗、新药筛选、肿瘤标志物开发与鉴定等，为临床提 …See details»
D1 Medical Technology (Shanghai) Co., Ltd. - synapse.zhihuiya.com
The aim of this study is to use single-cell sequencing technology to explore neuroendocrine neoplasm (NEN) molecular biological characteristics, tumor heterogeneity and cell subtypes. …See details»
丹望医疗-类器官技术的领导者 - d1med.com
1.在干细胞、3D培养或类器官领域有一定的研究，特别是具有病人来源肿瘤组织培养经验。能独立自主摸索不同肿瘤类器官的 ...See details»
D1 Medical Technology (Shanghai) Co., Ltd.: Drug pipelines, …
Explore D1 Medical Technology (Shanghai) Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial.See details»
D1med (丹望医疗) - Tech in Asia
D1med (丹望医疗) is an organoid technology research and development and service provider.See details»
D1 Medical Technology - PitchBook
Feb 8, 2021 Information on valuation, funding, cap tables, investors, and executives for D1 Medical Technology. Use the PitchBook Platform to explore the full profile.See details»
丹望医疗科技（杭州）有限公司 - 爱企查
丹望医疗科技（杭州）有限公司是一家瞪羚企业 (2022)、科技型中小企业 (2024)、高新技术企业 (2022)、小微企业，该公司成立于2019年11月19日，位于浙江省杭州市钱塘区白杨街道科技 …See details»
丹望医疗重磅推出VOS高通量微流控类器官制备系统 | 解决领域内 …
Oct 15, 2024 D1Med 丹望医疗是全球领先的研发和生产类器官疾病模型和类器官芯片的高科技公司，致力于将最新的类器官技术应用于药物开发、疾病诊疗、再生 ...See details»
丹望医疗-类器官技术的领导者 - d1med.com
Hans Clevers教授发现Lgr5是肠道干细胞的标志物，并成功建立首个肠道干细胞体外3D类器官培养体系，开创了类器官作为疾病模型的研究时代。 Hans Clevers教授发表论文600余篇，引用 …See details»
dMed | Clinipace announce corporate name change to Caidya
Oct 3, 2022 SHANGHAI and MORRISVILLE, N.C., October 3, 2022 – dMed | Clinipace, the established clinical research organization serving global innovators, such as biotechs, …See details»
【首发】丹望医疗完成1.2亿人民币A轮融资，加速推进类器官临床 …
Oct 14, 2021 这是丹望医疗在12个月内完成的第2轮融资，所募集资金将主要用于加速类器官标准化自动化技术升级，产能提高与优化、产品注册申报、临床试验推进和新药研发服务拓展。 …See details»
丹望医疗-类器官技术的领导者 - d1med.com
08.08 2024新品首发！D1MED芯片灌注摇床震撼上市！ 08.08 2024国家干细胞资源库开展类器官资源共享 11.02 2015 该研究成功建立20个结直肠癌病人的肿瘤组织类器官 11.19 2022首次报 …See details»
丹望医疗科技（上海）有限公司_www.d1med.com
Oct 12, 2024 丹望医疗科技（上海）有限公司：公司是国内领先的专注类器官技术的平台型公司。公司致力于采用最先进的类器官技术，为临床提供肿瘤精准医疗新方案，为药物研发企业提 …See details»
D1med类器官芯片 - 丹望医疗-类器官技术的领导者
丹望医疗科技（上海）有限公司，是国内领先的专注类器官技术的平台型公司。公司致力于将最新的再生医学临床转化技术，应用于疾病诊疗、新药筛选、肿瘤标志物开发与鉴定等，为临床提 …See details»
MilliporeSigma Supporting Innovation in China with D1Med …
Oct 8, 2020 MilliporeSigma is collaborating with D1Med, a Shanghai-based biopharmaceutical start-up precision-medical company, to accelerate production of D1Med’s 3D cell culture …See details»
D1MED芯片灌注摇床震撼上市 - vbdata.cn
Aug 5, 2024 D1Med芯片灌注摇床新品上市，模拟人体器官功能，适用于新药研发、个性化医疗，可通过手机蓝牙远程调整参数，验证数据显示流体刺激对细胞生长分化有显著影响，并展示 …See details»
Merck Supporting Innovation in China with D1Med Collaboration
Oct 8, 2020 Merck is collaborating with D1Med, a Shanghai-based biopharmaceutical start-up precision-medical company, to accelerate production of D1Med’s 3D cell culture technology …See details»
产品与服务 - 丹望医疗-类器官技术的领导者 - d1med.com
02 D1 Medical Technology 关于我们技术类器官疾病模型库产品服务资料下载公司动态加入丹望隐私声明 电话：86-021-69106895 邮箱：[email protected] 地址： 上海市奉贤区高丰路706 …See details»
新闻中心 - 丹望医疗-类器官技术的领导者 - d1med.com
10.30 2024 类器官模型——人肺类器官 丹望医疗使用肺组织中分离出的肺气道上皮细胞进行3D培养与扩增，构建的人肺支气管类器官多次传代后仍保持良好生长能力。 10.22 2024 年终回馈 | …See details»